Kim Sang-Hwan, Ko Young-Bong, Lee Young-Kyun, Hong Seok-Woo, Choi Hyung-Jin, Ha Yong-Chan, Shin Chan-Soo
Department of Orthopaedic Surgery, Seoul National University Bundang Hospital, Seongnam, Korea.
Department of Orthopaedic Surgery, Chung-Ang University College of Medicine, Seoul, Korea.
J Bone Metab. 2013 Nov;20(2):99-103. doi: 10.11005/jbm.2013.20.2.99. Epub 2013 Nov 18.
Calcium is prescribed worldwide for patients diagnosed with osteoporosis. However, the national utilization of calcium and compliance with calcium is unclear in Korea. Our purpose is to evaluate Korea's national utilization of calcium and compliance with calcium in patients with osteoporotic hip fracture from 2007 to 2010 using data from the Health Insurance Review and Assessment (HIRA) Service.
From 2007 to 2011, osteoporotic hip fractures were identified using the International Classification of Diseases, 10th revision (ICD-10) and procedure code form from the nationwide database of the Health Insurance Review and Assessment Service. Compliant users of calcium were defined as the patients' medication possession ratio of 80 or more. We analyzed the compliance of calcium according to age and gender.
Among 85,228 patients with hip fracture, 20,800 patients (24.4%) received a prescription of a calcium supplement. Among them, only 1,692 patients (8.1%) were identified as compliant users of calcium. The proportion of compliant users was higher in women than men in all age groups. The proportion of compliant users decreased with age in women.
In Korea, the national utilization of calcium was low and compliance with calcium was unsatisfactory even in patients with osteoporotic hip fracture.
全球范围内,钙制剂都被用于治疗骨质疏松症患者。然而,韩国国内钙制剂的使用情况以及患者对钙的依从性尚不清楚。我们的目的是利用健康保险审查与评估(HIRA)服务的数据,评估2007年至2010年韩国骨质疏松性髋部骨折患者的全国钙制剂使用情况及对钙的依从性。
2007年至2011年期间,使用国际疾病分类第10版(ICD - 10)和健康保险审查与评估服务全国数据库中的程序代码形式,识别骨质疏松性髋部骨折。钙的依从性使用者定义为患者药物持有率达到80%或更高。我们根据年龄和性别分析了钙的依从性。
在85228例髋部骨折患者中,20800例(24.4%)接受了钙补充剂处方。其中,只有1692例(8.1%)被确定为钙的依从性使用者。在所有年龄组中,女性依从性使用者的比例高于男性。女性依从性使用者的比例随年龄增长而下降。
在韩国,即使是骨质疏松性髋部骨折患者,钙制剂的全国使用率也较低,对钙的依从性也不尽人意。